IMNM logo

IMNM
Immunome Inc

2,225
Mkt Cap
$2.54B
Volume
308,027.00
52W High
$27.65
52W Low
$5.15
PE Ratio
-9.25
IMNM Fundamentals
Price
$22.20
Prev Close
$22.45
Open
$22.12
50D MA
$22.55
Beta
1.44
Avg. Volume
1.55M
EPS (Annual)
-$2.43
P/B
4.00
Rev/Employee
$39,214.69
$1,226.67
Loading...
Loading...
News
all
press releases
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Immunome (NASDAQ:IMNM) Stock Price Up 9.4% - What's Next?
Immunome (NASDAQ:IMNM) Shares Up 9.4% - Time to Buy...
MarketBeat·2d ago
News Placeholder
Philip Wagenheim Sells 28,200 Shares of Immunome (NASDAQ:IMNM) Stock
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Philip Wagenheim sold 28,200 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $20.65, for a total value of $582,330.00. Following the completion of the sale, the...
MarketBeat·9d ago
News Placeholder
Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Philip Wagenheim sold 28,200 shares of Immunome stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $20.65, for a total transaction of $582,330.00. Following the sale, the director owned 341,147 shares...
MarketBeat·10d ago
News Placeholder
Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Philip Wagenheim sold 36,800 shares of the company's stock in a transaction on Friday, March 20th. The shares were sold at an average price of $20.47, for a total transaction of $753,296.00. Following the sale, the director directly owned...
MarketBeat·10d ago
News Placeholder
Pivotal bioVenture Partners Investment Advisor LLC Invests $5.88 Million in Immunome, Inc. $IMNM
Pivotal bioVenture Partners Investment Advisor LLC acquired a new position in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) in the third quarter, according to its most recent Form 13F filing...
MarketBeat·19d ago
News Placeholder
Immunome (NASDAQ:IMNM) Director Jean Jacques Bienaime Purchases 1,000 Shares of Stock
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Jean Jacques Bienaime acquired 1,000 shares of the firm's stock in a transaction dated Wednesday, March 11th. The shares were purchased at an...
MarketBeat·20d ago
News Placeholder
Immunome (NASDAQ:IMNM) Director Acquires $21,550.00 in Stock
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Jean Jacques Bienaime acquired 1,000 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The stock was...
MarketBeat·21d ago
News Placeholder
Immunome (IMNM) to Release Earnings on Wednesday
Immunome (NASDAQ:IMNM) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...
MarketBeat·22d ago
News Placeholder
Immunome (NASDAQ:IMNM) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded Immunome from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·26d ago
<
1
2
...
>

Latest IMNM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.